What's Happening?
Myriad Genetics, a molecular diagnostic testing company based in Salt Lake City, has partnered with Amazon Web Services (AWS) to improve its AI-driven document processing capabilities. The company processes approximately 1.5 million diagnostic tests annually,
which requires extensive paperwork for revenue cycle management. Initially, Myriad developed an AI tool to automate document processing, but high costs led them to collaborate with AWS. The new AI system has significantly reduced document processing time from 10 minutes to 20 seconds per document, thereby accelerating repayment cycles. This collaboration aims to streamline operations and improve efficiency in handling insurance claims and reimbursements.
Why It's Important?
The partnership between Myriad Genetics and AWS highlights the growing trend of leveraging AI to optimize business operations in the healthcare sector. By reducing document processing times, Myriad can expedite insurance claims and improve cash flow, which is crucial for maintaining financial stability. This development also underscores the importance of AI in enhancing operational efficiency and reducing costs in healthcare, potentially leading to faster patient care and improved service delivery. The collaboration could set a precedent for other healthcare organizations seeking to integrate AI into their revenue cycle management processes.
What's Next?
Myriad plans to expand the use of its AI tool, Image Genius, to other business units, including oncology and mental health, by 2027. The company aims to further integrate AI across all aspects of its revenue cycle, including eligibility verification and claims submission. This expansion could lead to broader adoption of AI in healthcare, encouraging other companies to explore similar partnerships to enhance their operational capabilities.
